key: cord-0933504-eq4z4o4v
authors: Gombar, Saurabh; Bergquist, Timothy; Pejaver, Vikas; Hammarlund, Noah E.; Murugesan, Kanagavel; Mooney, Sean; Shah, Nigam; Pinsky, Benjamin A.; Banaei, Niaz
title: SARS-CoV-2 infection and COVID-19 severity in individuals with prior seasonal coronavirus infection
date: 2021-02-09
journal: Diagn Microbiol Infect Dis
DOI: 10.1016/j.diagmicrobio.2021.115338
sha: f710a19f227abafcb6fa5fd500f4c368e0b55786
doc_id: 933504
cord_uid: eq4z4o4v

We show that individuals with documented history of seasonal coronavirus have a similar SARS-CoV-2 infection rate and COVID-19 severity as those with no prior history of seasonal coronavirus. Our findings suggest prior infection with seasonal coronavirus does not provide immunity to subsequent infection with SARS-CoV-2.

.

We also did not observe a higher SARS-CoV-2 positivity rate in patients ≥65 vs <65 years old in groups with a history of either positive or negative seasonal coronavirus result (data not shown). Lastly, in those with COVID-19, the proportion of patients with severe (defined as hospitalized and intubated) or moderate (defined as hospitalized but not intubated) infection was comparable to those with history of positive and negative seasonal coronavirus test results (40.0% (4/10) vs 48.1% (37/77), P = 0.63) ( Table 2 ).

Our findings suggest past infection with seasonal coronavirus, and thus by inference cross-reactive memory T cell immune response to SARS-CoV-2, do not provide protective immunity against subsequent infection with SARS-CoV-2 infection and also do not modulate the severity of COVID-19 in those that get infected by SARS-CoV-2. Our findings are consistent with the lack of protection against SARS-CoV-2 infection in children with prior infection with seasonal coronavirus based on seropositivity (7) . Retrospective studies with larger number of participants and prospective studies in individuals with pre-existing crossreactive memory T cells are needed to confirm lack of protective immunity to SARS-CoV-2 or modulation of COVID-19 severity in individuals with pre-existing cross-reactive T cells to seasonal coronaviruses. Table 1 . SARS-CoV-2 RT-PCR positivity rate in patients with history of seasonal coronavirus (OC43, HKU1, 229E and NL63) prior to COVID-19 pandemic. 

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Single-Cell Transcriptomic Analysis of SARS-CoV-2

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome

Prior infection by seasonal coronaviruses does not prevent SARS-CoV-2 infection and associated Multisystem Inflammatory Syndrome in children